[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,129,682
  • Shares Outstanding, K 69,264
  • Annual Sales, $ 2,708 M
  • Annual Income, $ 247,100 K
  • EBIT $ 474 M
  • EBITDA $ 564 M
  • 60-Month Beta 1.47
  • Price/Sales 4.92
  • Price/Cash Flow 30.40
  • Price/Book 8.92

Options Overview Details

View History
  • Implied Volatility 56.09% (+2.29%)
  • Historical Volatility 32.68%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 56.09% on 04/24/26
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 20) 19.72 (10.40%)
  • Put/Call Vol Ratio 0.47
  • Today's Volume 497
  • Volume Avg (30-Day) 147
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 5,835
  • Open Int (30-Day) 5,829
  • Expected Range 169.84 to 209.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.14
  • Number of Estimates 8
  • High Estimate $1.29
  • Low Estimate $0.97
  • Prior Year $1.02
  • Growth Rate Est. (year over year) +11.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
186.25 +1.78%
on 04/24/26
227.24 -16.58%
on 03/25/26
-35.94 (-15.94%)
since 03/24/26
3-Month
186.25 +1.78%
on 04/24/26
275.92 -31.30%
on 01/26/26
-82.04 (-30.21%)
since 01/23/26
52-Week
186.25 +1.78%
on 04/24/26
354.88 -46.58%
on 11/20/25
-69.82 (-26.92%)
since 04/24/25

Most Recent Stories

More News
Insulet Corporation Earnings Preview: What to Expect

Insulet Corporation is set to announce its first-quarter earnings next month, and Wall Street expects the company’s EPS to increase by double digits.

XLV : 144.18 (-1.41%)
$SPX : 7,165.08 (+0.80%)
PODD : 189.56 (-1.38%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

NEW YORK , April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD). Such investors are advised...

PODD : 189.56 (-1.38%)
PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky

Insulet Corp. Stock Falls After Voluntary Medical Device Correction Reveals Omnipod 5 Insulin-Leakage Defect Affecting Thousands of Pods

PODD : 189.56 (-1.38%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

NEW YORK , April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD).  Such investors are advised...

PODD : 189.56 (-1.38%)
2 High-Flying Stocks to Own for Decades and 1 We Turn Down

2 High-Flying Stocks to Own for Decades and 1 We Turn Down

TWI : 8.22 (+0.37%)
VRT : 323.46 (+0.53%)
PODD : 189.56 (-1.38%)
Stock Index Futures Slip as Trump’s Hormuz Deadline Looms

June S&P 500 E-Mini futures (ESM26) are down -0.26%, and June Nasdaq 100 E-Mini futures (NQM26) are down -0.38% this morning as investors remain wary ahead of President Trump’s deadline for Iran to...

APP : 448.29 (-1.29%)
NVDA : 208.27 (+4.32%)
HUM : 215.23 (+0.13%)
AVGO : 422.76 (+0.67%)
ASML.NA : 1,249.600 (+2.11%)
MU : 496.72 (+3.11%)
UNH : 354.92 (+0.10%)
ELV : 344.76 (-0.44%)
ESM26 : 7,194.75s (+0.72%)
TSLA : 376.30 (+0.69%)
STX : 586.25 (-0.23%)
AMD : 347.81 (+13.91%)
PODD ALERT: Levi & Korsinsky Investigates Insulet Corporation on Behalf of Shareholders Who Lost Money

New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Insulet Corporation (NASDAQ: PODD) ("Insulet Corporation") concerning...

PODD : 189.56 (-1.38%)
Insulet (PODD): 3 Reasons We Love This Stock

Insulet (PODD): 3 Reasons We Love This Stock

PODD : 189.56 (-1.38%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD

NEW YORK , April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD). Such investors are advised...

PODD : 189.56 (-1.38%)
PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Device Defect: Levi & Korsinsky

Insulet Corp. Stock Falls After Voluntary Medical Device Correction Reveals Omnipod 5 Insulin-Leakage Defect Affecting Thousands of Pods

PODD : 189.56 (-1.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 195.83
2nd Resistance Point 193.25
1st Resistance Point 191.41
Last Price 189.56
1st Support Level 186.98
2nd Support Level 184.40
3rd Support Level 182.56

See More

52-Week High 354.88
Fibonacci 61.8% 290.46
Fibonacci 50% 270.57
Fibonacci 38.2% 250.67
Last Price 189.56
52-Week Low 186.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.